Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Generating Antibiotic Incentives Now Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Prescription Drug User Fee Act (no specific bill); incentives for antibiotic research and development (H.R. 2182); hepatitis C education (no specific bill); improvements to vaccine immunization (no specific bill); 340b (no specific bill)
Generating Antibiotic Incentives Now Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Reauthorization of the Prescription Drug User Fee Act (H.R. 5651; S. 3187); incentives for antibiotic research and development (H.R. 2182; H.R. 5651; S. 3187); hepatitis C education (no specific bill); improvements to vaccine immunization (no specific bill); 340b (no specific bill).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MERCK & CO INC via MERCK & CO, INC.
2012 · second_quarter · Q2
Reauthorization of the Prescription Drug User Fee Act (H.R. 5651; S. 3187); incentives for antibiotic research and development (H.R. 2182; H.R. 5651; S. 3187); hepatitis C education (no specific bill); improvements to vaccine immunization (no specific bill); 340b (no specific bill).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO INC via MERCK & CO, INC.
2012 · first_quarter · Q1
Source: Senate LDA
Preserving Access to Life-Saving Medications Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Supply chain safety (no specific bill); pharmaceutical shortages (H.R. 2245, S. 296)
Medicare Decisions Accountability Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Food and Drug Administration Reform Act of 2012
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Reauthorization of the Prescription Drug User Fee Act (H.R. 5651; S. 3187); incentives for antibiotic research and development (H.R. 2182; H.R. 5651; S. 3187); hepatitis C education (no specific bill); improvements to vaccine immunization (no specific bill); 340b (no specific bill).
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Generating Antibiotic Incentives Now Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Prescription Drug User Fee Act (no specific bill); importation of pharmaceuticals (no specific bill); incentives for antibiotic research and development (H.R. 2182); hepatitis C education (no specific bill); pharmaceutical shortages (S. 296, H.R. 2245)
Generating Antibiotic Incentives Now Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Prescription Drug User Fee Act reauthorization (no specific bill); importation of pharmaceuticals (no specific bill); incentives for antibiotic research and development (H.R. 2182); hepatitis C education (no specific bill); improvements to immunizations (no specific bills); health literacy (no specific bills); adherence (no specific bill)
Generating Antibiotic Incentives Now Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Prescription Drug User Fee Act (no specific bill); importation of pharmaceuticals (no specific bill); incentives for antibiotic research and devlopment (H.R. 2182); hepatitis C education (no specific bill); pharmaceutical shortages (S. 296, HR. 2245)
Preserving Access to Life-Saving Medications Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Prescription Drug User Fee Act (no specific bill); importation of pharmaceuticals (no specific bill); incentives for antibiotic research and devlopment (H.R. 2182); hepatitis C education (no specific bill); pharmaceutical shortages (S. 296, HR. 2245)
Preserving Access to Life-Saving Medications Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Prescription Drug User Fee Act (no specific bill); importation of pharmaceuticals (no specific bill); incentives for antibiotic research and development (H.R. 2182); hepatitis C education (no specific bill); pharmaceutical shortages (S. 296, H.R. 2245)
United States-Korea Free Trade Agreement Implementation Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Korea Free Trade Agreement (H.R. 3080); TranPacific Partnership
Medicare Decisions Accountability Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, S. 668)
Medicare Decisions Accountability Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, S. 668)
Medicare Decisions Accountability Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, S. 668)
Medicare Decisions Accountability Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, S. 668)
American Research and Competitiveness Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); renewal and expansion of the R&D tax credit (H.R. 942); repatriation (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill).
American Research and Competitiveness Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); renewal and expansion of the R&D tax credit (H.R. 942); repatriation (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income.
American Research and Competitiveness Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); renewal and expansion of the R&D tax credit (H.R. 942; S 1577); repatriation (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill).
American Research and Competitiveness Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); renewal and expansion of teh R&D tax credit (H.R. 942); repatriation (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill).
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation); efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590); Expansion of, or increase in, Medicaid rebates (H.R. 3200; S. 1796; H.R. 3590; H.R. 4872)
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590). Expansion of or increase in Medicaid rebate (H.R. 3200; S. 1796;H.R. 3590; H.R. 4872).
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization. Implementation of the Independent Payment Advisory Board provisions of health care reform bill (H.R. 3590). Reauthorization of the Prescription Drug User Fee Act (no specific bill).
Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.
Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.
Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.
Patient-Centered Outcomes Research Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Patient-Centered Outcomes Research Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590). Expansion of or increase in Medicaid rebate (H.R. 3200; S. 1796;H.R. 3590; H.R. 4872).
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation); efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590); Expansion of, or increase in, Medicaid rebates (H.R. 3200; S. 1796; H.R. 3590; H.R. 4872)
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
A resolution supporting the goals and ideals of National Hepatitis Awareness Month and World Hepatitis Day.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.
A resolution supporting the goals and ideals of National Hepatitis Awareness Month and World Hepatitis Day.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.
A resolution supporting the goals and ideals of National Hepatitis Awareness Month and World Hepatitis Day.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.
A resolution supporting the goals and ideals of National Hepatitis Awareness Month and World Hepatitis Day.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization. Implementation of the Independent Payment Advisory Board provisions of health care reform bill (H.R. 3590). Reauthorization of the Prescription Drug User Fee Act (no specific bill).
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Health Care Reform implementation; Awareness and treatment of viral hepatitis; Implementation of the Independent Payment Advisory Board provisions of health care reform bill (H.R. 3590); Reauthorization of the Prescription Drug User Fee Act (no specific bill); Importation of pharmaceuticals from foreign markets.
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Change in formula for Average Manufacturers' Price for Medicaid. Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs and to ensure appropriate access to vaccines under Medicare (no specific legislation). Implementation of the Independent Payment Advisory Board provisions of health care reform bill (H.R. 3590).
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation); efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590); Expansion of, or increase in, Medicaid rebates (H.R. 3200; S. 1796; H.R. 3590; H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization. Implementation of the Independent Payment Advisory Board provisions of health care reform bill (H.R. 3590). Reauthorization of the Prescription Drug User Fee Act (no specific bill).
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590). Expansion of or increase in Medicaid rebate (H.R. 3200; S. 1796;H.R. 3590; H.R. 4872).
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation); efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590); Expansion of, or increase in, Medicaid rebates (H.R. 3200; S. 1796; H.R. 3590; H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590). Expansion of or increase in Medicaid rebate (H.R. 3200; S. 1796;H.R. 3590; H.R. 4872).
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (HR 3200; America's Healthy Futures Act of 2009). Oppose expansion of or increase in Medicaid rebate (HR 3200; American's Healthy Futures Act of 2009).
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; America's Healthy Futures Act of 2009)
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
America's Affordable Health Choices Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (HR 3200; S. 1796; H.R. 3590). Oppose expansion of or increase in Medicaid rebate (HR 3200; S.1796; H.R. 3590).
Patient-Centered Outcomes Research Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; maintaining market based, private sector health care delivery system. (no specific legislation)
Patient-Centered Outcomes Research Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; America's Healthy Futures Act of 2009)
Patient-Centered Outcomes Research Act of 2009
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; America's Healthy Futures Act of 2009)
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (HR 3200; S. 1796; H.R. 3590). Oppose expansion of or increase in Medicaid rebate (HR 3200; S.1796; H.R. 3590).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; maintaining market based, private sector health care delivery system. (no specific legislation)
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; America's Healthy Futures Act of 2009)
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; maintaining market based, private sector health care delivery system. (no specific legislation)
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (HR 3200; S. 1796; H.R. 3590). Oppose expansion of or increase in Medicaid rebate (HR 3200; S.1796; H.R. 3590).
American Middle Class Tax (AMT) Relief Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
Medicare Prescription Drug Price Negotiation Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Medicare Prescription Drug Price Negotiation Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Medicare Prescription Drug Price Negotiation Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Medicare Prescription Drug Price Negotiation Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Medicare Improvements for Patients and Providers Act of 2008
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Medicare Improvements for Patients and Providers Act of 2008
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Issues related to Physician Payments Sunshine Act of 2007 (S. 2029)
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Support demonstration projects to assess the short-term and long-term effectiveness of obesity management programs (no specific bill). Support congressional interest in obesity awareness efforts (no specific bill). Issues related to Physician Payments Sunshine Act of 2007 (S. 2029).
Medicare Enhancements for Needed Drugs Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Medicare Enhancements for Needed Drugs Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Medicare Enhancements for Needed Drugs Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Medicare Enhancements for Needed Drugs Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Support amendments to Patent reform legislation concerning post-grant review authority, apportionment of damages and inequitable conduct provisions (S. 1145, H.R. 1908).
Support amendments to patent reform legislation concerning post-grant review authority, apportionment of damages, venue and inequitable conduct provisions (S. 1145, H.R. 1908)
Food and Drug Administration Amendments Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900). Support efforts to promote public/private partnerships for health technology assessment (no specific legislation). Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill).
Food and Drug Administration Amendments Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900) Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation).
Medicare Prescription Drug Price Negotiation Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Merdicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Medicare Prescription Drug Price Negotiation Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900) Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation).
Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900). Support efforts to promote public/private partnerships for health technology assessment (no specific legislation). Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill).
Support amendments to patent reform legislation concerning post-grant review authority, apportionment of damages, venue and inequitable conduct provisions (S. 1145, H.R. 1908)
Support amendments to Patent reform legislation concerning post-grant review authority, apportionment of damages and inequitable conduct provisions (S. 1145, H.R. 1908).
Medicare Enhancements for Needed Drugs Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Merdicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Medicare Enhancements for Needed Drugs Act of 2007
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
To designate the facility of the United States Postal Service located at 115 West Pine Street in Hattiesburg, Mississippi, as the "Major Henry A. Commiskey, Sr. Post Office Building".
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Support efforts to add HPV vaccines to the list of taxable vaccines for purposes of the Vaccine Injury Compensation Trust Fund (H.R. 5495)
Supply chain safety (no specific bill); pharmaceutical shortages (H.R. 2245, S. 296)
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Prescription Drug User Fee Act (no specific bill); incentives for antibiotic research and development (H.R. 2182); hepatitis C education (no specific bill); improvements to vaccine immunization (no specific bill); 340b (no specific bill)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO INC via MERCK & CO, INC.
2011 · fourth_quarter · Q4
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, S. 668)
Korea Free Trade Agreement (H.R. 3080); TranPacific Partnership
Deficit Reduction (no specific bill)
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); renewal and expansion of the R&D tax credit (H.R. 942; S 1577); repatriation (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill).
Prescription Drug User Fee Act reauthorization (no specific bill); importation of pharmaceuticals (no specific bill); incentives for antibiotic research and development (H.R. 2182); hepatitis C education (no specific bill); improvements to immunizations (no specific bills); health literacy (no specific bills); adherence (no specific bill)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
2011 · third_quarter · Q3
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, S. 668)
Prescription Drug User Fee Act (no specific bill); importation of pharmaceuticals (no specific bill); incentives for antibiotic research and development (H.R. 2182); hepatitis C education (no specific bill); pharmaceutical shortages (S. 296, H.R. 2245)
Patent Reform (H.R. 1249)
Deficit Reduction (no specific bill); WTO Cotton Agreement (H.R. 2112)
Korea, Panama and Colombia Free Trade Agreements (no specifc bills); TransPacific Partnership
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); renewal and expansion of teh R&D tax credit (H.R. 942); repatriation (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO INC via MERCK & CO, INC.
2011 · second_quarter · Q2
Deficit reduction (no specific bill); WTO Cotton agreement (H.R. 2112); FDA funding (H.R. 2112); ADAP funding (no specific bill)
Prescription Drug User Fee Act (no specific bill); importation of pharmaceuticals (no specific bill); incentives for antibiotic research and devlopment (H.R. 2182); hepatitis C education (no specific bill); pharmaceutical shortages (S. 296, HR. 2245)
Patent Reform (H.R. 1249)
Korea, Colombia and Panama Free Trade Agreements (no specific bills); data exclusivity in free trade agrements (no specific bills)
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, S. 668)
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); renewal and expansion of the R&D tax credit (H.R. 942); repatriation (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO INC via MERCK & CO, INC.
2011 · first_quarter · Q1
Prescription Drug User Fee Act (no specific bill); importation of pharmaceuticals (no specific bill).
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, S. 668)
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); renewal and expansion of the R&D tax credit (H.R. 942); repatriation (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income.
MERCK & CO INC via MERCK & CO, INC.
2010 · first_quarter · 1A
Rx drug importation into the US, other than by drug manufacturer (no specific bill); requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill); promote public/private partnerships for comparative effectiveness assessments (S. 1213); Physician Payments Sunshine Act of 2009 (S. 301); health care reform; increasing coverage of uninsured; coverage of preventative services; including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation); efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590); Expansion of, or increase in, Medicaid rebates (H.R. 3200; S. 1796; H.R. 3590; H.R. 4872)
MERCK & CO INC via MERCK & CO, INC.
2010 · fourth_quarter · Q4
Health Care Reform implementation; Awareness and treatment of viral hepatitis; Implementation of the Independent Payment Advisory Board provisions of health care reform bill (H.R. 3590); Reauthorization of the Prescription Drug User Fee Act (no specific bill); Importation of pharmaceuticals from foreign markets.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO INC via MERCK & CO, INC.
2010 · third_quarter · Q3
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization. Implementation of the Independent Payment Advisory Board provisions of health care reform bill (H.R. 3590). Reauthorization of the Prescription Drug User Fee Act (no specific bill).
Change in formula for Average Manufacturers' Price for Medicaid. Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs and to ensure appropriate access to vaccines under Medicare (no specific legislation). Implementation of the Independent Payment Advisory Board provisions of health care reform bill (H.R. 3590).
MERCK & CO INC via MERCK & CO, INC.
2010 · second_quarter · 2A
Change in formula for Average Manufacturers' Price for Medicaid. Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs and to ensure appropriate access to vaccines under Medicare (no specific legislation).
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO INC via MERCK & CO, INC.
2010 · second_quarter · 2A
Change in formula for Average Manufacturers' Price for Medicaid. Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs and to ensure appropriate access to vaccines under Medicare (no specific legislation).
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO INC via MERCK & CO, INC.
2010 · second_quarter · Q2
Change in formula for Average Manufacturers' Price for Medicaid. Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs and to ensure appropriate access to vaccines under Medicare (no specific legislation).
Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO INC via MERCK & CO, INC.
2010 · first_quarter · Q1
RX drug importation into the US, other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Promote public/private partnerships for comparative effectiveness assessment (S. 1213). Physician Payments Sunshine Act of 2009 (S. 301). Health care reform; increasing coverage of uninsured; coverage of preventative services, including immunizations; expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization; maintaining market-based, private sector health care delivery system. (H.R. 3200; S. 1679; S. 1796; H.R. 3590; H.R. 4872)
Efforts to amend the Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Efforts to ensure appropriate access to vaccines under Medicare (H.R. 3200; S. 1796; H.R. 3590). Expansion of or increase in Medicaid rebate (H.R. 3200; S. 1796;H.R. 3590; H.R. 4872).
MERCK & CO INC via MERCK & CO, INC.
2009 · fourth_quarter · Q4
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (HR 3200; S. 1796; H.R. 3590). Oppose expansion of or increase in Medicaid rebate (HR 3200; S.1796; H.R. 3590).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; prevent 340B pricing expansion; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; S. 1796; H.R. 3590)
MERCK & CO INC via MERCK & CO, INC.
2009 · third_quarter · Q3
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (HR 3200; America's Healthy Futures Act of 2009). Oppose expansion of or increase in Medicaid rebate (HR 3200; American's Healthy Futures Act of 2009).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; support efforts to gain coverage of preventive services, including immunizations; maintaining market-based, private sector health care delivery system. (HR 3200; S. 1679; America's Healthy Futures Act of 2009)
MERCK & CO INC via MERCK & CO, INC.
2009 · second_quarter · Q2
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (S.1213). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; maintaining market based, private sector health care delivery system. (no specific legislation)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
MERCK & CO INC via MERCK & CO, INC.
2009 · first_quarter · Q1
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific legislation). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Issues related to Physician Payments Sunshine Act of 2009 (S. 301). Issues related to health care reform; increasing coverage of uninsured; maintaining market based, private sector health care delivery system. (no specific legislation)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
MERCK & CO INC via MERCK & CO, INC.
2008 · fourth_quarter · Q4
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 09 Budget and Labor-HHS Appropriations bills). Support increased funding for FDA (FY 09 Agriculture Appropriations bill).
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Issues related to Physician Payments Sunshine Act of 2007 (S. 2029)
MERCK & CO INC via MERCK & CO, INC.
2008 · third_quarter · Q3
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Support demonstration projects to assess the short-term and long-term effectiveness of obesity management programs (no specific bill). Support congressional interest in obesity awareness efforts (no specific bill). Issues related to Physician Payments Sunshine Act of 2007 (S. 2029).
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 09 Budget and Labor-HHS Appropriations bills). Support increased funding for FDA (FY 09 Agriculture Appropriations bill).
MERCK & CO INC via MERCK & CO, INC.
2008 · second_quarter · Q2
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Support demonstration projects to assess the short-term and long-term effectiveness of obesity management programs (no specific bill). Support congressional interest in obesity awareness efforts (no specific bill).
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
MERCK & CO INC via MERCK & CO, INC.
2008 · first_quarter · Q1
Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Support demonstration projects to assess the short-term and long-term effectiveness of obesity management programs (no specific bill).
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
MERCK & CO INC via MERCK & CO, INC.
2007 · year_end · YY
Support amendments to patent reform legislation concerning post-grant review authority, apportionment of damages, venue and inequitable conduct provisions (S. 1145, H.R. 1908)
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Merdicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900) Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation).
MERCK & CO INC via MERCK & CO, INC.
2007 · mid_year · MM
Support amendments to Patent reform legislation concerning post-grant review authority, apportionment of damages and inequitable conduct provisions (S. 1145, H.R. 1908).
Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900). Support efforts to promote public/private partnerships for health technology assessment (no specific legislation). Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill).
MERCK & CO INC via MERCK & CO, INC.
2006 · year_end · YY
Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill).
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 2007 Labor-HHS Approprations bills)
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (no specific bill) Support efforts to ensure appropriate access to vaccines under Medicare Part D (no specific bill)
Supplemental examination (S. 23)
Deficit reduction (no specific bill)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 09 Budget and Labor-HHS Appropriations bills). Support increased funding for FDA (FY 09 Agriculture Appropriations bill).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 09 Budget and Labor-HHS Appropriations bills). Support increased funding for FDA (FY 09 Agriculture Appropriations bill).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Educate members of Congress, USTR, Commerce, State on compulsory licenses in Thailand and Brazil (no specific legislation). Support intellectual property protections in trade negotiations. (Peru FTA, Panama FTA, Columbia FTA, Korea FTA).
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 2008 Labor-HHS Appropriations bills) Support increased funding for FDA (FY 2008 Agriculture Appropriations bills).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 2008 Labor-HHS Appropriations bills) Support increased funding for FDA (FY 2008 Agriculture Appropriations bills).
Educate members of Congress, USTR, Commerce, State on compulsory licenses in Thailand and Brazil (no specific legislation). Support intellectual property protections in trade negotiations. (Peru FTS, Panama FTA, Coumbia FTA, Korea FTA).
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Support efforts to add HPV vaccines to the list of taxable vaccines for purposes of the Vaccine Injury Compensation Trust Fund (H.R. 5495)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office